A family is demanding answers over how the Health Insurance Organisation (HIO) makes and reviews decisions concerning the continuation of patients’ treatment abroad.
The case involves a Cypriot woman enrolled in a specialised neurological rehabilitation programme. In an open letter to the HIO, the Health Ministry and the House of Representatives, a family member argues that the case exposes a broader institutional gap.
The family is asking what happens when a decision to stop or alter treatment is challenged, but the review or legal process takes time that may prove critical to the patient’s recovery.
To protect the patient’s personal and medical information, the family has not disclosed any details that could identify her.
According to the letter, the woman suffered a serious accident and underwent major medical and surgical procedures in Cyprus. Her doctors subsequently determined that she required specialised rehabilitation abroad.
The family says she travelled following medical recommendations and with the approval of the relevant state authorities. Responsibility for issuing the necessary approvals was later transferred to the HIO.
A recent decision rejected the continuation of her treatment at the specific overseas centre on the grounds that it could be continued in Cyprus. The family disputes the decision and says it intends to exercise its legal rights.
Time as part of treatment
The first issue raised concerns the protection available to a patient while a disputed decision is being reviewed.
The family questions what meaningful protection exists when an appeal or court procedure could take months, while treatment cannot simply be placed on hold.
It argues that, in healthcare, time is not merely a procedural consideration but part of the treatment itself.
“If the examination of an objection or court appeal takes months or years, the right of appeal risks becoming theoretical if critical treatment time has meanwhile been lost,” the letter says.
Treatment available in Cyprus
Another point of contention is the conclusion that the patient’s treatment can continue in Cyprus.
The family argues that the presence of neurologists, physical medicine and rehabilitation doctors, or general rehabilitation centres does not in itself demonstrate that an equivalent level of care is available in the country.
According to the letter, the patient is currently receiving specialised early neurological rehabilitation for people with severe acquired brain injuries, disorders of consciousness, or complex neurological and medical needs.
The family says any meaningful comparison should not be limited to whether the relevant medical specialties exist in Cyprus. It should establish whether a specific unit can accept the patient at her present stage, whether it has assessed and agreed to take her case, and whether it can provide the necessary standard of care.
“If these have not been secured, then the general conclusion that ‘treatment can continue in Cyprus’ does not adequately address the actual medical and therapeutic issue,” the letter says.
Questions over air transfer
The family is particularly concerned by information that the patient may be flown back to Cyprus on Monday, 14 September.
It says it learned of the possible transfer through third parties rather than through an official notification from the HIO. At the time the letter was written, the family had not been told where the patient would be transferred, who would take responsibility for her treatment, or what rehabilitation programme had been arranged.
It is also asking whether the patient’s doctors have assessed whether she can safely travel by air and who would assume medical responsibility for such a decision.
The family wants clarification on whether a medical team in Cyprus has already assessed and accepted the patient, and whether full communication has taken place between her doctors abroad and those who may assume her care in Cyprus.
It also claims it was not given sufficient time to consider the available options, including whether it could continue the existing treatment at its own expense.
Appeal to House Health Committee
The open letter calls on the House Health Committee to examine the matter immediately.
The family says it is not asking Parliament to determine which treatment the patient requires. Instead, it wants MPs to examine who exercises meaningful and effective oversight of disputed HIO decisions.
The central question is whether any institution or procedure can protect a patient immediately when the standard objection or court process cannot be completed before valuable treatment time is lost.
The family also links the issue to compulsory contributions to the General Healthcare System, arguing that because participation is required by law, the system must provide citizens with equally meaningful protection.
The letter concludes with a question that it says extends beyond this individual case:
“If such a decision is proven to have been wrong, but critical and irrecoverable rehabilitation time has meanwhile been lost, what form of redress can truly return to the patient what they have lost?”
The family is seeking “immediate, public and specific answers” from the HIO and the relevant institutions.
